Risk assessment [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2014-09-24 05:34 (4291 d 20:18 ago) – Posting: # 13561
Views: 18,621

Hi Ohlbe,

❝ That's all very fine for efficacy. But what about safety ?


That’s not really covered in the paper since the authors explored only bioinequivalence at the lower end (T/R 70%) of 400 mg. However, higher IR strengths of 600, 650, and 800 mg (CR 1,000 mg) are on the European market; note that 400/0.7 < 600. Above 400 mg the PK is less than dose proportional. The maximum daily dose is 2,400 mg. In the Biowaiver Monograph the risk was assessed as being low.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
137 visitors (0 registered, 137 guests [including 26 identified bots]).
Forum time: 01:53 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5